Zomedica Announces $7 Million Second Tranche Closing of Preferred Shares
10 juin 2019 06h00 HE
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., June 10, 2019 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (TSX-V: ZOM) (“Zomedica” or “Company”), a veterinary diagnostic and pharmaceutical company,...
Zomedica Announces Achievement of Product Development Milestones on its TRUFORMA™ Point-of-Care Diagnostic Platform
21 mai 2019 06h55 HE
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., May 21, 2019 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (TSX-V: ZOM), a veterinary diagnostic and pharmaceutical company, today announced that...
Zomedica Announces First Quarter 2019 Financial Results
10 mai 2019 17h21 HE
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., May 10, 2019 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (TSX-V:ZOM) (“Zomedica” or “Company”), a veterinary diagnostic and pharmaceutical company, today...
Zomedica Announces Private Placement of Preferred Shares
10 mai 2019 06h00 HE
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., May 10, 2019 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (TSX-V: ZOM) (“Zomedica” or “Company”), a veterinary diagnostic and pharmaceutical company,...
Zomedica Announces 2018 Annual Meeting Results
15 août 2018 16h15 HE
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., Aug. 15, 2018 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (TSX-V:ZOM) (“Zomedica” or “Company”), a veterinary diagnostic and pharmaceutical company,...
Zomedica Pharmaceuticals Corp. Announces Second Quarter 2018 Financial Results
09 août 2018 16h01 HE
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (TSX-V:ZOM) (“Zomedica” or “Company”), a veterinary diagnostic and pharmaceutical company,...
Zomedica to Participate in the Bank of America Merrill Lynch Animal Health Summit
20 févr. 2018 06h55 HE
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., Feb. 20, 2018 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (TSX-V:ZOM) (“Zomedica” or “Company”), a veterinary diagnostic and pharmaceutical company,...
Zomedica Pharmaceuticals Corp. Enters into License and Supply Agreement with Celsee, Inc. for Cancer Liquid Biopsy Platform
21 déc. 2017 06h55 HE
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., Dec. 21, 2017 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (TSX-V:ZOM) (“Zomedica” or “Company”), a veterinary pharmaceutical and diagnostic company,...
Zomedica Announces Achievement of Therapeutic Development Milestones
12 déc. 2017 06h55 HE
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., Dec. 12, 2017 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (TSX-V:ZOM) (“Zomedica” or “Company”), a veterinary pharmaceutical and diagnostic company,...
Zomedica Pharmaceuticals Corp. Registration Statement Declared Effective by U.S. Securities and Exchange Commission
20 nov. 2017 18h51 HE
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., Nov. 20, 2017 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (TSX-V:ZOM) (NYSE American:ZOM) (Zomedica or the Company), a veterinary pharmaceutical and health care solutions...